AI Bias Analysis
4 models · Takes ~15 seconds
Seaport Therapeutics Inc., a clinical-stage biotechnology company focused on antidepressants and anxiety drugs, is seeking to raise $212.4 million in a US initial public offering.
Source
Bloomberg Markets
Opens original article in a new tab
Qualcomm will be working alongside MediaTek to develop a smartphone chip for OpenAI, with manufacturer Luxshare co-designing the device, an analyst said.
The transaction will add roughly 370,000 barrels of oil equivalent per day to Shell's portfolio and is designed to boost the firm's long-term production.
The Swatch Group AG is facing renewed investor pressure after a key proxy adviser Institutional Shareholder Services recommended shareholders support a board candidate backed by a US activist.
